PMP22 Gene CMT1E NGS Genetic DNA Test
Introduction to the Test
The PMP22 Gene CMT1E NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with Charcot-Marie-Tooth disease (CMT), a hereditary neurological disorder. This test utilizes Next-Generation Sequencing (NGS) technology to provide accurate and comprehensive results, enabling healthcare providers to make informed decisions regarding patient care.
What the Test Measures
This genetic test specifically measures alterations in the PMP22 gene, which is crucial for the proper functioning of peripheral nerves. By analyzing the genetic material, the test can detect mutations that may lead to CMT, helping to confirm a diagnosis and guide treatment options.
Who Should Consider This Test?
Individuals experiencing symptoms such as muscle weakness, sensory loss, or difficulties with balance may benefit from this test. Additionally, those with a family history of CMT or related neurological disorders should consider genetic testing to assess their risk and understand their genetic background.
Benefits of Taking the Test
- Accurate diagnosis of Charcot-Marie-Tooth disease.
- Guidance for treatment options and management strategies.
- Informed decisions regarding family planning and genetic counseling.
- Peace of mind for patients and their families.
Understanding Your Results
Results from the PMP22 Gene CMT1E NGS Genetic DNA Test will provide insights into the presence of genetic mutations. A genetic counselor or neurologist will help interpret the results, discussing implications for health management and potential next steps.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| PMP22 Gene CMT1E NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Booking the Test
To book the PMP22 Gene CMT1E NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and provide any additional information you may need.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient undergoing the test and a genetic counseling session to draw a pedigree chart of family members affected with PMP22 Gene CMT1E.
For more information about the test and its implications, consult with a neurologist or a genetics specialist today.
